Thyroid test revolution: new study seeks better way to monitor hormone levels
NCT ID NCT06083636
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether measuring a different thyroid hormone (fT3) or the ratio of two hormones (fT3/fT4) can give a clearer picture of thyroid health in people taking levothyroxine. It includes 500 adults with various types of hypothyroidism who are on a stable dose of the medication. The goal is to improve lab tests for patients where the usual TSH test isn't reliable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2022
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults with hypothyroidism using levothyroxine (L-T4) attending the outpatient clinic of Amsterdam UMC will be included. Healthy euthyroid controls will be recruited amongst employees of Amsterdam UMC.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: In order to be eligible to participate in this study, a hypothyroid subject must meet all of the following criteria: * Ability to provide informed consent * Ability to speak and understand Dutch or English * Intake of a stable dosage of levothyroxine, meaning the dosage of levothyroxine must not be changed during the appointment at the outpatient clinic * Diagnosis of one these forms of hypothyroidism * Patients with primary hypothyroidism: euthyroid based on TSH according to physician * Patients with hypothyroidism after a total thyroidectomy due to thyroid carcinoma (therefore athyroid): on target TSH according to physician (target TSH depending on stage/severity of carcinoma) * Patients using L-T4 due to therapy of Graves' disease: euthyroid based on TSH according to physician (TSH cannot be suppressed, namely TSH within reference interval of 0,5-5,0 mU/L) * Patients with central hypothyroidism: euthyroid based on fT4 according to physician (common is fT4 in the upper limit, reference interval is 12-22 pmol/L) In order to be eligible to participate in this study, a healthy control subject must meet all of the following criteria: * Ability to provide informed consent; * Ability to speak and understand Dutch or English * Consider themselves healthy Exclusion Criteria: A potential hypothyroid subject who meets any of the following criteria will be excluded from participation in this study: * Not euthyroid according to physician * Pregnancy * Patients using L-T4 due to therapy of Graves' disease: if TSH is still suppressed * Any of the following medication * Liothyronine (Cytomel) * Iodide * Oral contraceptives * Active treatment of malignancy (other than thyroid carcinoma) A potential healthy control subject who meets any of the following criteria will be excluded from participation in this study: * Pregnancy * Any of the following medication * Thyroid medication (a.o. levothyroxine, thiamazol, PTU) * Lithium * Amiodarone * Propranolol * Iodide * Glucocorticoids * Oral contraceptives * Heparin * Growth hormone * Active treatment of malignancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Central hypothyroidism are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, North Holland, 1105 AZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Underactive thyroid may worsen liver scarring in fatty liver disease
- Thyroid trouble may worsen liver scarring in fatty liver disease
- Could millions of seniors ditch a daily thyroid pill?
- Vitamin e may shield the thyroid: a new trial tests the Antioxidant's power
- Does feeling stigmatized worsen life quality for men with low testosterone?
- Can a pig thyroid extract tame hypothyroidism?